Skip to main content
VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.640
+0.001 (0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

VYNE Therapeutics Revenue

In the year 2025, VYNE Therapeutics had annual revenue of $570.00K with 13.77% growth. VYNE Therapeutics had revenue of $130.00K in the quarter ending December 31, 2025, with 54.76% growth.

Revenue (ttm)
$570.00K
Revenue Growth
+13.77%
P/S Ratio
37.41
Revenue / Employee
$57,000
Employees
10
Market Cap
21.32M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025570.00K69.00K13.77%
Dec 31, 2024501.00K77.00K18.16%
Dec 31, 2023424.00K-53.00K-11.11%
Dec 31, 2022477.00K-454.00K-48.76%
Dec 31, 2021931.00K-20.06M-95.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Marker Therapeutics 3.55M
OSR Holdings 2.91M
Vistagen Therapeutics 789.00K
Exicure 500.00K
Lexaria Bioscience 368.00K
Allarity Therapeutics 320.00K
Revenue Rankings

VYNE News

More News